Shattuck Labs (STTK) Other Non-Current Assets (2019 - 2026)
Shattuck Labs' (STTK) quarterly Other Non-Current Assets came in at $2.0 million in Q1 2026, up 6.73% year-on-year from $1.9 million in Q1 2025, and up 40.22% on a QoQ basis from $1.4 million in Q4 2025.
Shattuck Labs (STTK) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 6.73% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 6.73% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, down 28.93% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.0 million, up from $1.4 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for STTK reached as high as $3.2 million in Q1 2022 and fell as low as $1.4 million in Q4 2025.
- Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $2.5 million in 2023.
- Across the five-year window, Other Non-Current Assets soared 1066.67% in 2022 and dropped 28.93% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $3.1 million in 2022, then slipped by 17.24% to $2.5 million in 2023, then fell by 20.39% to $2.0 million in 2024, then slipped by 28.93% to $1.4 million in 2025, then soared by 40.22% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.0 million in Q1 2026, $1.4 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 2.67 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 3.23 Mn |
| Dec 31, 2021 | 381,000.00 |
| Sep 30, 2021 | 273,000.00 |
| Jun 30, 2021 | 331,000.00 |